Edited By : Renée Deveney
This page features 4 Cited Research Articles
Fact Checked
Fact-Checked

Editors carefully fact-check all Consumer Notice, LLC content for accuracy and quality.

Consumer Notice, LLC has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Chemo Port Recall History: What Was and Wasn't Recalled

Bard (now a part of Becton, Dickinson and Company) issued a PowerPort recall in 2019 that affected 178 devices. This chemo port recall was not for the Chronoflex catheter fracture issue that is at the heart of over 2,800 PowerPort lawsuits

So far, despite hundreds of injury reports, Bard hasn’t issued a recall for catheter fractures. The company has stated that it stands behind the safety of its products.

FDA Recall Details and Adverse Event Reports

According to the FDA recall details, the 2019 Bard PowerPort recall involved 178 devices that may have contained the wrong catheter tip. Bard didn’t report any injuries associated with this recall, but it said the wrong catheter tip could prolong surgery for some patients.

Despite the FDA receiving hundreds of MAUDE adverse event reports for PowerPort injuries such as blood clots, infections and catheter fractures, Bard has not issued a recall. There hasn’t been an FDA chemo port warning for this issue either.

Other Chemo Port Recalls — A Reference for Port Patients

The FDA has issued recalls for several brands of implanted port catheters in recent years. We’ve included a brief reference to the most notable actions below.

The most serious of these recalls is the 2025 Smiths Medical ProPort recall. The FDA has stated that the defective device can lead to serious injury and death.

DeviceManufacturerYearFDA ClassRecall ReasonRecall Type
SmartPort CTAngioDynamics2009Class IIDevice kit may contain wrong-sized componentVoluntary
Smart Port CTAngioDynamics2021Class IISterility failure — packaging compromiseVoluntary
Vortex MP PortAngioDynamics2022Class IIMissing safety instructionsVoluntary
Deltec ProPortSmiths Medical2025Class IManufacturing defect — port housing separationVoluntary
Class I = FDA's most serious recall classification. Class II = device may cause temporary or medically reversible injury.

All of the recalls were voluntarily reported by the manufacturer, and none of the recalls mentioned above involve Chronoflex catheter fracture issues.

While there are currently over 2,800 Bard PowerPort lawsuits that make up most of the chemo port litigation, port catheter problems involve multiple manufacturers. For example, AngioDynamics port lawsuits also allege these chemo ports can cause injuries.

Bard PowerPort Problems the Recall Doesn't Cover

Bard PowerPort recalls don’t always cover all the port catheter side effects patients experience, and lawsuits allege PowerPort catheters made with a defective material called Chronoflex can break and cause blood clots, infections or organ failure that can be fatal. The FDA has received hundreds of reports of these issues, but there hasn’t been a recall for these specific problems.

For example, in one FDA report, a patient complained of chest pain, and doctors found that a piece of a fractured PowerPort catheter had travelled to her heart. Another FDA report said a PowerPort patient complained of chest pain that went up the side of her neck and head, and ER doctors found she had blood clots. 

If you had a chemo port removed after an injury such as a broken catheter, infection or a blood clot, you may not have known the device could be defective because there wasn’t a recall. 

“What’s important for people to understand is that the litigation isn’t just about recalled models. The claims we’re filing focus on systemic design flaws that make many versions of the PowerPort prone to fracture or failure, even if they were never officially recalled,” product liability attorney Moshe Horn of Simmons Hanly Conroy told Consumer Notice.

three icons representing filing a lawsuit
Suffering from serious injuries after your Bard PowerPort device failed?
Get your free case review today

Chemo Port Injuries and Who May Be Affected

People who require long-term medications, blood transfusions or nutritional support are the main people who can be affected by chemo port injuries, such as blood clots, infections and organ damage from catheter fractures — especially cancer patients.

Those who received a PowerPort and used it for months or years might not have realized symptoms such as fever, chest pain or repeated infections could be related to a defective chemo port.

Adults or children who may be affected by chemo port injuries include those who:
  • Require IV fluids or frequent blood draws
  • Need chemotherapy treatments for cancer
  • Require long-term IV antibiotics for a serious infection
  • Have inflammatory bowel disease (IBD) that requires IV nutrition or biotherapy
  • Require dialysis for kidney failure

In some cases, the chemo port may have led to long hospital stays because of infections that require strong antibiotic treatments. Your doctor might have mentioned that a piece of your chemo port broke off, or that you had to undergo treatment for blood clots and the port had to be removed.

People who experienced these injuries have filed lawsuits against Bard’s parent company, Becton Dickinson (BD). More than 2,800 cases have been grouped together in federal court (MDL 3081), and lawyers expect more to be filed.

MDL is short for multidistrict litigation, a process where a large group of similar cases is consolidated to make litigation cheaper and more efficient. You can join an MDL from anywhere in the country.

What to Do If You Had a Chemo Port and Were Injured

If you had a chemo port that broke or you suffered a chemo port injury, you can take steps to safeguard your health as well as look into your legal options. Here are a few steps you can take.

Step 1: Talk to your doctor
If you have a chemo port still in place, ask your doctor about monitoring it or what to do if you are experiencing problems. Don’t wait to tell your doctor if you are having symptoms such as pain, unexplained fever or difficulty breathing.
Step 2: Document your experience
Gather any records of port removal, hospitalization, infection or imaging that showed catheter problems.
Step 3: Understand your legal options
Thousands of patients have filed claims, and cases are still being accepted. You can look into filing a claim too.

If you’re interested in filing a lawsuit, a licensed attorney can investigate your chemo port experience by asking a few simple questions and let you know if you qualify for a product liability claim.

three icons representing filing a lawsuit
Suffering from serious injuries after your Bard PowerPort device failed?
Get your free case review today

Frequently Asked Questions About Chemo Port Recalls

Has the Bard PowerPort been recalled?
Yes, Bard recalled a few PowerPorts in 2019, but it hasn’t been recalled for catheter fractures.
What is the Bard PowerPort recall about?
The 2019 Bard recall was for kits that could contain the wrong tip part.
Is my chemo port safe?
Most chemo ports work as they’re supposed to and don’t cause issues, but if you experience symptoms such as chest pain, difficulty breathing or fever, it could be a sign that your port is causing problems. Make sure you seek medical attention right away.
Can I sue if my chemo port was recalled or failed?
You can’t typically sue just because a chemo port was recalled, but if you experience health problems due to a recalled or failed port, you can contact an attorney to see if you qualify for a lawsuit.
What injuries are linked to the Bard PowerPort?
Injuries linked to the Bard PowerPort include blood clots, infection, catheter fracture or the chemo port moving from its original location and requiring surgery or device removal.
Please seek the advice of a qualified professional before making decisions about your health or finances.
Last Modified: March 12, 2026

4 Cited Research Articles

Consumernotice.org adheres to the highest ethical standards for content production and references only credible sources of information, including government reports, interviews with experts, highly regarded nonprofit organizations, peer-reviewed journals, court records and academic organizations. You can learn more about our dedication to relevance, accuracy and transparency by reading our editorial policy.

  1. United States Judicial Panel on Multidistrict Litigation. (2026, March 2). MDL Statistics Report - Distribution of Pending MDL Dockets by Actions Pending. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-March-2-2026.pdf
  2. U.S. Food & Drug Administration. (2026, February 19). Manufacture and User Facility Device Experience (MAUDE) Database. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm
  3. Becton, Dickinson and Company. (2023, August 8). Statement on Transfer of Bard PowerPort™ Implantable Port Cases to Multidistrict Litigation. Retrieved from https://www.bd.com/content/dam/bd-assets/na/peripheral-intervention/web-assets/us/documents/media_statement_port_mdl_final_20230808.pdf
  4. U.S. Food & Drug Administration. (2020, March 26). Class 2 Device Recall Power Port Implantable Port. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=179655